SCHEMBL28040159

SCHEMBL28040159

F[CH]Cc1cccc(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.54
TAAR1 Q96RJ0 3/20 0.50
HTR3E A5X5Y0 3/20 0.50
HTR3B O95264 3/20 0.50
HTR3A P46098 3/20 0.50
HTR3D Q70Z44 3/20 0.50
HTR3C Q8WXA8 3/20 0.50
IDO1 P14902 4/20 0.48
CYP3A4 P08684 2/20 0.48
AGXT P21549 2/20 0.48
CHRM2 P08172 2/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
AOC3 Q16853 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16507800 0.83 IDO1 (0.50) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL167780 0.80 PNMT (0.56) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL6158452 0.79 IDO1 (0.50) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL11670292 0.79 IDO1 (0.50) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL28879871 0.78 PNMT (0.54) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL771274 0.78 PNMT (0.54) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL7481246 0.78 PNMT (0.59) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL3084924 0.78 PNMT (0.54) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL6083088 0.78 HTR3E (0.55) PNMTTAAR1HTR3EHTR3BHTR3A
SCHEMBL27715138 0.77 PNMT (0.52) PNMTTAAR1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105408331-A Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic disorders Bayer Pharma AG 2016-03-16 CN claimed
CN-105408327-A Substituted benzoxazoles Bayer Pharma AG 2016-03-16 CN disclosed
CN-105408331-A Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic disorders Bayer Pharma AG 2016-03-16 CN disclosed